Ralimetinib dimesylate
CAS: 862507-23-1
Ref. TM-T6047
2mg | 59.00 € | ||
5mg | 83.00 € | ||
10mg | 129.00 € | ||
25mg | 245.00 € | ||
50mg | 442.00 € | ||
100mg | 485.00 € | ||
1ml*10 (DMSO) | 97.00 € |
Product Information
- LY2228820 dimesylate, Ralimetinib, LY2228820, Ralimetinib Mesylate
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
Chemical properties
Technical inquiry about: TM-T6047 Ralimetinib dimesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.